2026-09-10Bullish
+5.41%24 hours changeElevance reaffirmed its FY2026 earnings guidance in an 8-K filing and noted Q3 adjusted earnings are tracking ahead of expectations.
read the report →Elevance Health is a leading health benefits company serving over 45 million medical members. It operates through Health Benefits, CarelonRx, and Carelon Services.
stitched from the price window carried by each report
Elevance reaffirmed its FY2026 earnings guidance in an 8-K filing and noted Q3 adjusted earnings are tracking ahead of expectations.
read the report →Q2 earnings beat was driven by non-recurring items while core health margins compressed and Medicaid losses led to market exits.
read the report →Stock fell 8.54% after Q2 earnings revealed low quality beat, severe Medicaid margin compression, and an implied 2H guidance downgrade.
read the report →